Abstract
The MEN2A oncogene encodes for a constitutive active member of the RET receptor tyrosine kinase family. Here, we report that MEN2A-RET activates Signal Transducer and Activator of Transcription 3 (STAT3) via two YxxV/Q STAT3 docking sites, Tyr752 and Tyr928. MEN2A-RET induces both Tyr705 and Ser727 phosphorylation of STAT3, and STAT3 serine phosphorylation is required for its maximal transcriptional activity. Stable NIH3T3 cell lines expressing both MEN2A-RET and STAT3α but not STAT3β, are characterized by enhanced proliferation and cyclin-D1 promoter activity, and enhanced growth in soft agar. These data indicate that malignant cell growth induced by MEN2A-RET involves its activation of STAT3.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alberti L, Borrello MG, Ghizzoni S, Torriti F, Rizzetti MG, Pierotti MA . 1998 Oncogene 17: 1079–1087
Arighi E, Alberti L, Torriti F, Ghizzoni S, Rizzetti MG, Pelicci G, Pasini B, Bongarzone I, Piutti C, Pierotti MA, Borrello MG . 1997 Oncogene 14: 773–782
Asai N, Iwashita T, Matsuyama M, Takahashi M . 1995 Mol. Cell Biol. 15: 1613–1619
Asai N, Murakami H, Iwashita T, Takahashi M . 1996 J. Biol. Chem. 271: 17644–17649
Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA . 1996 Mol. Cell Biol. 16: 2151–2163
Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L . 1995 Oncogene 11: 2419–2427
Bowman T, Garcia R, Turkson J, Jove R . 2000 Oncogene 19: 2474–2488
Brasier AR, Tate JE, Habener JF . 1989 Biotechniques 7: 1116–1122
Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE . 1998 Mol. Cell Biol. 18: 2553–2558
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE . 1999 Cell 98: 295–303
Caldenhoven E, van-Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, De-Groot RP . 1996 J. Biol. Chem. 271: 13221–13227
Cao X, Tay A, Guy GR, Tan YH . 1996 Mol. Cell Biol. 16: 1595–1603
Coffer PJ, Koenderman L, De Groot RP . 2000 Oncogene 19: 2511–2522
Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415–1421
Delegeane AM, Ferland LH, Mellon PL . 1987 Mol. Cell Biol. 7: 3994–4002
DeLellis RA . 1995 Lab. Invest. 72: 494–505
Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells Jr SA . 1993 Hum. Mol. Genet. 2: 851–856
Durick K, Wu RY, Gill GN, Taylor SS . 1996 J. Biol. Chem. 271: 12691–12694
Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T . 1998 EMBO J. 17: 6670–6677
Goodfellow PJ, Wells Jr SA . 1995 J. Natl. Cancer Inst. 87: 1515–1523
Graham FL, Van der Eb AJ . 1973 Mol. Cell Biol. 2: 607–616
Heim MH, Kerr IM, Stark GR, Darnell Jr JE . 1995 Science 267: 1347–1349
Heinrich PC, Behrmann I, Muller NG, Schaper F, Graeve L . 1998 Biochem. J. 334: 297–314
Herber B, Truss M, Beato M, Muller R . 1994 Oncogene 9: 1295–1304
Ihle JN . 1996 Cell 84: 331–334
Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W . 1998 J. Biol. Chem. 273: 21145–21152
Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M . 2001 Oncogene 20: 1929–1938
Lin TS, Mahajan S, Frank DA . 2000 Oncogene 19: 2496–2504
Liu X, Vega QC, Decker RA, Pandey A, Worby CA, Dixon JE . 1996 J. Biol. Chem. 271: 5309–5312
Lorenzo MJ, Gish GD, Houghton C, Stonehouse TJ, Pawson T, Ponder BA, Smith DP . 1997 Oncogene 14: 763–771
Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L . 1993 Nature 363: 458–460
Pandey A, Liu X, Dixon JE, di Fiore PP, Dixit VM . 1996 J. Biol. Chem. 271: 10607–10610
Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott R, Ibanez CF . 2001 Neuron 29: 171–184
Pasini A, Geneste O, Legrand P, Schlumberger M, Rossel M, Fournier L, Rudkin BB, Schuffenecker I, Lenoir GM, Billaud M . 1997 Oncogene 15: 393–402
Ponder BA . 1999 Cancer Res. 59: 1736s–1741s
Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH . 1995 Science 267: 381–383
Schindler C, Darnell Jr JE . 1995 Annu. Rev. Biochem. 64: 621–651
Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V . 1994 Nature 367: 380–383
Schuringa JJ, Jonk LJ, Dokter WH, Vellenga E, Kruijer W . 2000a Biochem. J. 347: Pt 1 89–96
Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E . 2000b Blood 95: 3765–3770
Segouffin-Cariou C, Billaud M . 2000 J. Biol. Chem. 275: 3568–3576
Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R . 2000 Oncogene 19: 5419–5427
Song JI, Grandis JR . 2000 Oncogene 19: 2489–2495
Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE, Yancopoulos GD . 1995 Science 267: 1349–1353
Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H . 1988 Oncogene 3: 571–578
Takahashi M, Cooper GM . 1987 Mol. Cell Biol. 7: 1378–1385
Taraviras S, Marcos-Gutierrez CV, Durbec P, Jani H, Grigoriou M, Sukumaran M, Wang LC, Hynes M, Raisman G, Pachnis V . 1999 Development 126: 2785–2797
Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R . 1998 Mol. Cell Biol. 18: 2545–2552
Wen Z, Zhong Z, Darnell Jr JE . 1995 Cell 82: 241–250
Zong C, Yan R, August A, Darnell Jr JE, Hanafusa H . 1996 EMBO J. 15: 4515–4525
Zong CS, Zeng L, Jiang Y, Sadowski HB, Wang LH . 1998 J. Biol. Chem. 273: 28065–28072
Acknowledgements
This work was supported by grants from the Dutch Cancer Foundation (RUG 96-1217) and RUG 00-2316).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schuringa, J., Wojtachnio, K., Hagens, W. et al. MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 20, 5350–5358 (2001). https://doi.org/10.1038/sj.onc.1204715
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204715
Keywords
This article is cited by
-
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
Nature Reviews Clinical Oncology (2018)
-
STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma
Cancer Gene Therapy (2015)
-
Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy
Scientific Reports (2015)
-
KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer
Molecular Cancer (2014)
-
RET revisited: expanding the oncogenic portfolio
Nature Reviews Cancer (2014)